Anti-Cancer Agents in Medicinal Chemistry

(Formerly Current Medicinal Chemistry - Anti-Cancer Agents)


Simone Carradori
Department of Pharmacy
“G. d’Annunzio” University of Chieti-Pescara

Personal Subscription
Become EABM
Become Reviewer

Editorial [Hot Topic: SOD Enzymes and Their Mimics in Cancer: Pro- vs Anti-Oxidative Mode of Action-Part I (Guest Editor: Ines Batinic-Haberle)] promotion: free to download

Volume:11   Issue: 2
Pp: 172-174
Ines Batinic-Haberle
DOI: 10.2174/187152011795255885

Superoxide Dismutases: Anti- Versus Pro- Oxidants?

Volume:11   Issue: 2
Pp: 175-177
Irwin Fridovich
DOI: 10.2174/187152011795255966

Does More MnSOD Mean More Hydrogen Peroxide?

Volume:11   Issue: 2
Pp: 178-180
Lee Ann MacMillan-Crow and John P. Crow
DOI: 10.2174/187152011795255939

Mitochondrial Superoxide Dismutase - Signals of Distinction

Volume:11   Issue: 2
Pp: 181-190
Sumitra Miriyala, Aaron K. Holley and Daret K. St Clair
DOI: 10.2174/187152011795255920

Manganese Superoxide Dismutase (Sod2) and Redox-Control of Signaling Events That Drive Metastasis

Volume:11   Issue: 2
Pp: 191-201
Nadine Hempel, Pauline M. Carrico and J. Andres Melendez
DOI: 10.2174/187152011795255911

Cellular Redox Modulator, ortho Mn(III) meso-tetrakis(N-n-Hexylpyridinium-2-yl)porphyrin, MnTnHex-2-PyP5+ in the Treatment of Brain Tumors

Volume:11   Issue: 2
Pp: 202-212
Stephen T. Keir, Mark W. Dewhirst, John P. Kirkpatrick, Darell D. Bigner and Ines Batinic-Haberle
DOI: 10.2174/187152011795255957

Redox-Active Quinones and Ascorbate: An Innovative Cancer Therapy That Exploits the Vulnerability of Cancer Cells to Oxidative Stress

Volume:11   Issue: 2
Pp: 213-221
Julien Verrax, Raphael Beck, Nicolas Dejeans, Christophe Glorieux, Brice Sid, Rozangela C. Pedrosa, Julio Benites, David Vasquez, Jaime A. Valderrama and Pedro Buc Calderon
DOI: 10.2174/187152011795255902

Texaphyrins: Tumor Localizing Redox Active Expanded Porphyrins

Volume:11   Issue: 2
Pp: 222-232
Jonathan F. Arambula, Christian Preihs, Derric Borthwick, Darren Magda and Jonathan L. Sessler
DOI: 10.2174/187152011795255894

The Potential of Zn(II) N-Alkylpyridylporphyrins for Anticancer Therapy

Volume:11   Issue: 2
Pp: 233-241
Ludmil Benov, James Craik and Ines Batinic-Haberle
DOI: 10.2174/187152011795255975

The Ubiquitin+Proteasome Protein Degradation Pathway as a Therapeutic Strategy in the Treatment of Solid Tumor Malignancies

Volume:11   Issue: 2
Pp: 242-246
James J. Driscoll, Alex Minter, Daniel A. Driscoll and Jason K. Burris
DOI: 10.2174/187152011795255948